Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1979 1
1980 1
1982 1
1986 1
1987 1
1991 1
1992 1
1993 2
1994 4
1995 7
1996 7
1998 6
1999 5
2000 5
2001 3
2002 7
2003 4
2004 4
2005 3
2006 8
2007 14
2008 20
2009 19
2010 9
2011 13
2012 11
2013 12
2014 10
2015 9
2016 15
2017 16
2018 15
2019 11
2020 10
2021 6
2022 3
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.
Xu Y, Kong W, Cao M, Wang J, Wang Z, Zheng L, Wu X, Cheng R, He W, Yang B, Dong B, Pan J, Chen Y, Huang J, Jiang C, Zhai W, Li F, Chen R, Zhou X, Wu G, Geng X, Chen J, An H, Yuan Y, Xu T, Chen D, Lin D, Xu L, Huang K, Peng L, Yu Y, Tai S, Qi H, Luo K, Kang X, Wang H, Huang Y, Zhang J, Xue W. Xu Y, et al. Eur Urol. 2023 Feb;83(2):163-172. doi: 10.1016/j.eururo.2022.05.029. Epub 2022 Jun 15. Eur Urol. 2023. PMID: 35715365
DESIGN, SETTING, AND PARTICIPANTS: The study included 77 cases of FH-deficient RCC from 15 centers across China. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Clinical characteristics, molecular correlates, (18)F-fluorodeoxyglucose positron emission tomography/computed to …
DESIGN, SETTING, AND PARTICIPANTS: The study included 77 cases of FH-deficient RCC from 15 centers across China. OUTCOME MEASUREMENTS AND ST …
Surgical treatment of fibroids for subfertility.
Metwally M, Raybould G, Cheong YC, Horne AW. Metwally M, et al. Cochrane Database Syst Rev. 2020 Jan 29;1(1):CD003857. doi: 10.1002/14651858.CD003857.pub4. Cochrane Database Syst Rev. 2020. PMID: 31995657 Free PMC article.
BACKGROUND: Fibroids are the most common benign tumours of the female genital tract and are associated with numerous clinical problems including a possible negative impact on fertility. ...AUTHORS' CONCLUSIONS: There is limited evidence to determine the role of myomectomy …
BACKGROUND: Fibroids are the most common benign tumours of the female genital tract and are associated with numerous clinical problem …
Benign Metastasizing Leiomyoma.
Pacheco-Rodriguez G, Taveira-DaSilva AM, Moss J. Pacheco-Rodriguez G, et al. Clin Chest Med. 2016 Sep;37(3):589-95. doi: 10.1016/j.ccm.2016.04.019. Epub 2016 Jun 25. Clin Chest Med. 2016. PMID: 27514603 Review.
Skin manifestations associated with kidney cancer.
Amin A, Burgess EF. Amin A, et al. Semin Oncol. 2016 Jun;43(3):408-12. doi: 10.1053/j.seminoncol.2016.02.016. Epub 2016 Feb 23. Semin Oncol. 2016. PMID: 27178696 Review.
Kidney cancer is a heterogenous disease encompassing several distinct clinicopathologic entities with different underlying molecular aberrations and clinical outcomes. Renal cell carcinoma (RCC) has been shown to evoke immunologic responses that can impact the natural hist …
Kidney cancer is a heterogenous disease encompassing several distinct clinicopathologic entities with different underlying molecular aberrat …
Uterine Fibroids: Burden and Unmet Medical Need.
Al-Hendy A, Myers ER, Stewart E. Al-Hendy A, et al. Semin Reprod Med. 2017 Nov;35(6):473-480. doi: 10.1055/s-0037-1607264. Epub 2017 Nov 3. Semin Reprod Med. 2017. PMID: 29100234 Free PMC article. Review.
Nonmalignant Sequelae of Unconfined Morcellation at Laparoscopic Hysterectomy or Myomectomy.
Tulandi T, Leung A, Jan N. Tulandi T, et al. J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):331-7. doi: 10.1016/j.jmig.2016.01.017. Epub 2016 Jan 21. J Minim Invasive Gynecol. 2016. PMID: 26802909 Review.
Fifty-one articles met the inclusion criteria: 11 articles were related to endometriosis, adenomyosis, and endometrial hyperplasia; 30 articles parasitic myoma; and 9 disseminated peritoneal leiomyomatosis (DPL) and 1 DPL and endometriosis. We found that laparoscopic hyste …
Fifty-one articles met the inclusion criteria: 11 articles were related to endometriosis, adenomyosis, and endometrial hyperplasia; 30 artic …
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses.
El-Zaatari Z, Divatia MK. El-Zaatari Z, et al. Indian J Pathol Microbiol. 2020 Feb;63(Supplement):S7-S17. doi: 10.4103/IJPM.IJPM_877_19. Indian J Pathol Microbiol. 2020. PMID: 32108620 Review.
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant syndrome wherein affected individuals are at risk for the development of cutaneous leiomyomas, early-onset multiple uterine leiomyomas, and an aggressive subtype of renal cell cancer. ...Th …
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant syndrome wherein affected individuals are at risk …
Intravenous leiomyomatosis of the uterus: A clinicopathological analysis of nine cases and literature review.
Low HY, Zhao Y, Huang KS, Shen HP, Wu PJ, Tseng CJ. Low HY, et al. Taiwan J Obstet Gynecol. 2017 Jun;56(3):362-365. doi: 10.1016/j.tjog.2017.04.017. Taiwan J Obstet Gynecol. 2017. PMID: 28600049 Free article. Review.
OBJECTIVE: Intravenous/intravascular leiomyomatosis is characterized by intravenous proliferation of a histologically benign smooth muscle cell tumor mass that is non-tissue-invasive. ...We determine patients' characteristics, and recurrence and treatment of intravenous …
OBJECTIVE: Intravenous/intravascular leiomyomatosis is characterized by intravenous proliferation of a histologically benign smooth m …
Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.
Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomäki K, Tomlinson I, Richard S, Linehan WM. Menko FH, et al. Fam Cancer. 2014 Dec;13(4):637-44. doi: 10.1007/s10689-014-9735-2. Fam Cancer. 2014. PMID: 25012257 Free PMC article. Review.
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant condition in which susceptible individuals are at risk for the development of cutaneous leiomyomas, early onset multiple uterine leiomyomas and an aggressive form of type 2 papillary renal cel …
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant condition in which susceptible individuals are at ri …
Molecular diagnosis and therapy of kidney cancer.
Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, Srinivasan R. Linehan WM, et al. Annu Rev Med. 2010;61:329-43. doi: 10.1146/annurev.med.042808.171650. Annu Rev Med. 2010. PMID: 20059341 Free PMC article. Review.
Kidney cancer is not a single disease; it is made up of a number of cancers that occur in the kidney, each having a different histology, following a different clinical course, responding differently to therapy, and caused by a different gene. ...It is thought to be involve …
Kidney cancer is not a single disease; it is made up of a number of cancers that occur in the kidney, each having a different histology, fol …
242 results